Copyright Reports & Markets. All rights reserved.

Global Granisetron Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Granisetron Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Transdermal system
      • 1.4.3 Injection
      • 1.4.4 Oral
    • 1.5 Market by Application
      • 1.5.1 Global Granisetron Market Share by Application (2014-2025)
      • 1.5.2 Chemotherapy
      • 1.5.3 Post operative
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Granisetron Market Size
    • 2.2 Granisetron Growth Trends by Regions
      • 2.2.1 Granisetron Market Size by Regions (2014-2025)
      • 2.2.2 Granisetron Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Granisetron Market Size by Manufacturers
      • 3.1.1 Global Granisetron Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Granisetron Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Granisetron Market Concentration Ratio (CR5 and HHI)
    • 3.2 Granisetron Key Players Head office and Area Served
    • 3.3 Key Players Granisetron Product/Solution/Service
    • 3.4 Date of Enter into Granisetron Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Granisetron Market Size by Type (2014-2019)
    • 4.2 Global Granisetron Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Granisetron Market Size (2014-2019)
    • 5.2 Granisetron Key Players in United States
    • 5.3 United States Granisetron Market Size by Type
    • 5.4 United States Granisetron Market Size by Application

    6 Europe

    • 6.1 Europe Granisetron Market Size (2014-2019)
    • 6.2 Granisetron Key Players in Europe
    • 6.3 Europe Granisetron Market Size by Type
    • 6.4 Europe Granisetron Market Size by Application

    7 China

    • 7.1 China Granisetron Market Size (2014-2019)
    • 7.2 Granisetron Key Players in China
    • 7.3 China Granisetron Market Size by Type
    • 7.4 China Granisetron Market Size by Application

    8 Japan

    • 8.1 Japan Granisetron Market Size (2014-2019)
    • 8.2 Granisetron Key Players in Japan
    • 8.3 Japan Granisetron Market Size by Type
    • 8.4 Japan Granisetron Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Granisetron Market Size (2014-2019)
    • 9.2 Granisetron Key Players in Southeast Asia
    • 9.3 Southeast Asia Granisetron Market Size by Type
    • 9.4 Southeast Asia Granisetron Market Size by Application

    10 India

    • 10.1 India Granisetron Market Size (2014-2019)
    • 10.2 Granisetron Key Players in India
    • 10.3 India Granisetron Market Size by Type
    • 10.4 India Granisetron Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Granisetron Market Size (2014-2019)
    • 11.2 Granisetron Key Players in Central & South America
    • 11.3 Central & South America Granisetron Market Size by Type
    • 11.4 Central & South America Granisetron Market Size by Application

    12 International Players Profiles

    • 12.1 Kyowa Kirin
      • 12.1.1 Kyowa Kirin Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Granisetron Introduction
      • 12.1.4 Kyowa Kirin Revenue in Granisetron Business (2014-2019)
      • 12.1.5 Kyowa Kirin Recent Development
    • 12.2 Heron Therapeutics
      • 12.2.1 Heron Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Granisetron Introduction
      • 12.2.4 Heron Therapeutics Revenue in Granisetron Business (2014-2019)
      • 12.2.5 Heron Therapeutics Recent Development
    • 12.3 Fresenius Kabi
      • 12.3.1 Fresenius Kabi Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Granisetron Introduction
      • 12.3.4 Fresenius Kabi Revenue in Granisetron Business (2014-2019)
      • 12.3.5 Fresenius Kabi Recent Development
    • 12.4 Hikma Pharmaceuticals
      • 12.4.1 Hikma Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Granisetron Introduction
      • 12.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2014-2019)
      • 12.4.5 Hikma Pharmaceuticals Recent Development
    • 12.5 Teva
      • 12.5.1 Teva Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Granisetron Introduction
      • 12.5.4 Teva Revenue in Granisetron Business (2014-2019)
      • 12.5.5 Teva Recent Development
    • 12.6 Cipla
      • 12.6.1 Cipla Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Granisetron Introduction
      • 12.6.4 Cipla Revenue in Granisetron Business (2014-2019)
      • 12.6.5 Cipla Recent Development
    • 12.7 Sandoz
      • 12.7.1 Sandoz Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Granisetron Introduction
      • 12.7.4 Sandoz Revenue in Granisetron Business (2014-2019)
      • 12.7.5 Sandoz Recent Development
    • 12.8 Wockhardt
      • 12.8.1 Wockhardt Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Granisetron Introduction
      • 12.8.4 Wockhardt Revenue in Granisetron Business (2014-2019)
      • 12.8.5 Wockhardt Recent Development
    • 12.9 Mylan
      • 12.9.1 Mylan Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Granisetron Introduction
      • 12.9.4 Mylan Revenue in Granisetron Business (2014-2019)
      • 12.9.5 Mylan Recent Development
    • 12.10 APOTEX
      • 12.10.1 APOTEX Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Granisetron Introduction
      • 12.10.4 APOTEX Revenue in Granisetron Business (2014-2019)
      • 12.10.5 APOTEX Recent Development
    • 12.11 Dr.Reddy's
    • 12.12 Bluepharma
    • 12.13 Natco Pharma
    • 12.14 Akorn
    • 12.15 Taro Pharmaceutical
    • 12.16 Aurobindo

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
      In 2018, the global Granisetron market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Granisetron status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Granisetron development in United States, Europe and China.

      The key players covered in this study
      Kyowa Kirin
      Heron Therapeutics
      Fresenius Kabi
      Hikma Pharmaceuticals
      Teva
      Cipla
      Sandoz
      Wockhardt
      Mylan
      APOTEX
      Dr.Reddy's
      Bluepharma
      Natco Pharma
      Akorn
      Taro Pharmaceutical
      Aurobindo

      Market segment by Type, the product can be split into
      Transdermal system
      Injection
      Oral

      Market segment by Application, split into
      Chemotherapy
      Post operative

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Granisetron status, future forecast, growth opportunity, key market and key players.
      To present the Granisetron development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Granisetron are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now